🟢 Marker Therapeutics is trading 5% up today ahead of its expected August 13 earnings report

Marker Therapeutics is trading 5% up at $1.18, with investors looking ahead to the company’s expected August 13 earnings report and interim clinical update.

• No new company-specific announcement was identified for August 12, 2026.
• The move coincides with a stronger market following the July CPI report; the Nasdaq Composite is up 0.59%, supporting rate-sensitive growth stocks.